METASTATIC RENAL CELL CARCINOMA
Clinical trials for METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for Tough-to-Treat kidney cancer
Disease control TerminatedThis study tested a new oral pill called NKT2152 for adults with advanced kidney cancer that had stopped responding to standard treatments. The first part aimed to find a safe and effective dose. The second part planned to see how well the pill could shrink tumors and control the…
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Terminated trial tests Last-Chance drugs for tough kidney cancers
Disease control TerminatedThis study tested two different drug combinations for people with advanced kidney cancer that had stopped responding to standard treatments. The trial aimed to find safe doses and see if these combinations could shrink tumors or slow disease progression. The study was terminated …
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Study scans past data: is cancer drug safe for failing kidneys?
Knowledge-focused TerminatedThis study looked back at medical records to see if the cancer immunotherapy drug nivolumab caused different side effects in people with advanced kidney cancer, depending on how well their kidneys were working. It included 81 patients who had already received the drug as part of …
Matched conditions: METASTATIC RENAL CELL CARCINOMA
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:22 UTC